TheScreener - Chemical Works of Gedeon Richter Plc (RICHTER) RICHTER GEDEON reduced its risk exposure resulting in an upgrade to Slightly Positive

Report

TheScreener

EUR 14.32 For Business Accounts Only

RICHTER GEDEON reduced its risk exposure resulting in an upgrade to Slightly Positive

RICHTER GEDEON (DE), a company active in the Pharmaceuticals industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date February 18, 2022, the closing price was EUR 22.32 and its potential was estimated at EUR 25.81.

19/02/2022 1 EN

Underlying

Chemical Works of Gedeon Richter Plc

Chemical Works of Richter Gedeon is a multinational pharmaceutical company that is engaged in the research, development, production and marketing and trade of pharmaceutical products. Co.'s activities are divided into two major business segments: Pharmaceutical, including research, development and manufacturing of pharmaceutical products; and Wholesale and Retail including wholesale and retail trade through the distribution chain as well as marketing of its products. Co. is primarily engaged in production of gynecological, cardiovascular and gastroenterological products, antibiotics, antimicotics, OTC and medicines for treatment of the central nervous system.

See profile

HU0000123096 Budapest Stock Exchange Hungary

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

Concorde Securities

Guidance unchanged, clean EBIT beat estimates

Summary: Richter posted its Q3/24 results today morning. The Company matched the consensus for revenues at HUF 217bn, while the clean EBIT beat estimates by 3% as it came in at HUF 75bn. However, normal EBIT of HUF 64bn and net profit of HUF 37bn fell short of even our depressed expectation as an inventory impairment (HUF 9bn), provision (HUF 5bn) and an unrealized FX loss (HUF 20.8bn) dragged down earnings. The management fully reiterated its 2024 guidance. They continue to guide revenues to finish this year in the range of between EUR 2.15-2.25bn, while EBIT is seen in the range of be...

PREMIUM

November 13, 2024 November 13, 2024 5 EN

Concorde Securities

Guidance reiterated after a strong Q2 performance

Summary: Richter posted its Q2/24 results today morning. The Company beat analysts’ expectations across the board, slightly up in terms of revenues and gross profit, while the clean EBIT and net profit exceeded market expectations by 10% and 13%, respectively, despite a one-off impairment on inventories of HUF 7.6bn distorted the results. In EUR terms, Richter reached record quarterly sales of EUR 553mn. Favorable FX rates and lower taxation (Company noted that this is M&A-related and the globe tax base could be reduced by select items) provided some tailwind during Q2 as net profit tota...

PREMIUM

August 8, 2024 August 8, 2024 4 EN

Concorde Securities

Massive Q1 beat on FX gains, guidance reiterated

Summary: Richter posted its Q1/24 results today morning. The Company beat analysts’estimates across the board, slightly up in terms of revenues (+1%), gross profit (+1%) andEBIT (+1%), while the net income was much better than expected (+26%). This wasattributed to significant FX gains of HUF 15.2bn (o/w HUF 13.1bn was unrealized). Beforethe report, we estimated a positive impact on this line, but in a much smaller extent (+HUF6bn). Following a change in tax rules, taxes reached HUF 13.7bn (including all taxes in linewith GMT and deferred tax). As a result, net income reached HUF 68.2bn in Q1 ...

PREMIUM

May 17, 2024 May 17, 2024 4 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

RICHTER GEDEON reduced its risk exposure resulting in an upgrade to Slightly Positive

Empowering Investors

Guidance unchanged, clean EBIT beat estimates

Guidance reiterated after a strong Q2 performance

Massive Q1 beat on FX gains, guidance reiterated

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe